Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury

References

• Zuardi AW. Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Rev Bras Psiquiatr 2008;30:271–280
   PubMed Web of Science ®Google Scholar
• Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353:1685–1693
   PubMed Web of Science ®Google Scholar
• Fialkow L, Vieira SR, Fernandes AK, et al. Acute lung injury and acute respiratory distress syndrome at the intensive care unit of a general university hospital in Brazil. An epidemiological study using the American-European Consensus Criteria. Intensive Care Med 2002;28:1644–1648
   PubMed Web of Science ®Google Scholar
• Oliveira RH, Basille Filho A. Incidence of acute lung injury and acute respiratory distress syndrome in the intensive care unit of a university hospital: a prospective study. J Bras Pneumol 2006;32:35–42
   PubMedGoogle Scholar
• Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334–1349
   PubMed Web of Science ®Google Scholar
• Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012;122:2731–2740
   PubMed Web of Science ®Google Scholar
• Ribeiro A, Ferraz-de-Paula V, Pinheiro ML, et al. Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor. Eur J Pharmacol 2012;678:78–85
   PubMed Web of Science ®Google Scholar
• Ferreira CM, Chen JL, Li J, et al. Genetic interactions between chromosomes 11 and 18 contribute to airway hyperresponsiveness in mice. PLoS One 2012;7:e29579
   PubMed Web of Science ®Google Scholar
• Lino-dos-Santos-Franco A, Gimenes-Junior JA, Ligeiro-de-Oliveira AP, et al. Formaldehyde inhalation reduces respiratory mechanics in a rat model with allergic lung inflammation by altering the nitric oxide/cyclooxygenase-derived products relationship. Food Chem Toxicol 2013;59:731–738
   PubMed Web of Science ®Google Scholar
• Marini JJ, Slutsky AS. Physiological basis of ventilatory support. New York: Marcel Dekker; 1998
   Google Scholar
• Bates JH, Rincon M, Irvin CG. Animal models of asthma. Am J Physiol Lung Cell Mol Physiol 2009;297:L401–L410
   PubMed Web of Science ®Google Scholar
• Hantos Z, Daroczy B, Suki B, et al. Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol (1985) 1992;72:168–178
   PubMed Web of Science ®Google Scholar
• Tomioka S, Bates JH, Irvin CG. Airway and tissue mechanics in a murine model of asthma: alveolar capsule vs. forced oscillations. J Appl Physiol (1985) 2002;93:263–270
   PubMed Web of Science ®Google Scholar
• Bates JH, Irvin CG. Measuring lung function in mice: the phenotyping uncertainty principle. J Appl Physiol (1985) 2003;94:1297–1306
   PubMed Web of Science ®Google Scholar
• Irvin CG, Bates JH. Measuring the lung function in the mouse: the challenge of size. Respir Res 2003;4:4
   PubMed Web of Science ®Google Scholar
• Bates JH, Lutchen KR. The interface between measurement and modeling of peripheral lung mechanics. Respir Physiol Neurobiol 2005;148:153–164
   PubMed Web of Science ®Google Scholar
• Jonasson S, Hedenstierna G, Hjoberg J. Concomitant administration of nitric oxide and glucocorticoids improves protection against bronchoconstriction in a murine model of asthma. J Appl Physiol (1985) 2010;109:521–531
   PubMed Web of Science ®Google Scholar
• Goldblum SE, Wu KM, Jay M. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol (1985) 1985;59:1978–1985
   PubMed Web of Science ®Google Scholar
• Lutmer J, Watkins D, Chen CL, et al. Heparin-binding epidermal growth factor-like growth factor attenuates acute lung injury and multiorgan dysfunction after scald burn. J Surg Res 2013;185:329–337
   PubMed Web of Science ®Google Scholar
• D'Alessio FR, Tsushima K, Aggarwal NR, et al. CD4 + CD25 + Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest 2009;119:2898–2913
   PubMed Web of Science ®Google Scholar
• Ligeiro-Oliveira AP, Fialho de Araujo AM, Lazzarini R, et al. Effects of amphetamine on immune-mediated lung inflammatory response in rats. Neuroimmunomodulation 2004;11:181–190
   PubMed Web of Science ®Google Scholar
• Ligeiro de Oliveira AP, Lazzarini R, Cavriani G, et al. Effects of single or repeated amphetamine treatment and withdrawal on lung allergic inflammation in rats. Int Immunopharmacol 2008;8:1164–1171
   PubMed Web of Science ®Google Scholar
• Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interf Cytok Res 2009;29:313–326
   PubMed Web of Science ®Google Scholar
• Balamayooran G, Batra S, Balamayooran T, et al. Monocyte chemoattractant protein 1 regulates pulmonary host defense via neutrophil recruitment during Escherichia coli infection. Infect Immun 2011;79:2567–2577
   PubMed Web of Science ®Google Scholar
• Kishimoto S, Kobayashi Y, Oka S, et al. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. J Biochem 2004;135:517–524
   PubMed Web of Science ®Google Scholar
• Kozela E, Pietr M, Juknat A, et al. Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells. J Biol Chem 2010;285:1616–1626
   PubMed Web of Science ®Google Scholar
• Karmaus PW, Wagner JG, Harkema JR, et al. Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice. J Immunotoxicol 2013;10:321–328
   PubMed Web of Science ®Google Scholar
• Tanasescu R, Constantinescu CS. Cannabinoids and the immune system: an overview. Immunobiology 2010;215:588–597
   PubMed Web of Science ®Google Scholar
• Croxford JL, Yamamura T. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? J Neuroimmunol 2005;166:3–18
   PubMed Web of Science ®Google Scholar
• Costa B, Colleoni M, Conti S, et al. Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw. Naunyn Schmiedebergs Arch Pharmacol 2004;369:294–299
   PubMed Web of Science ®Google Scholar
• Liou GI, Auchampach JA, Hillard CJ, et al. Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor. Invest Ophthalmol Vis Sci 2008;49:5526–5531
   PubMed Web of Science ®Google Scholar
• Pan H, Mukhopadhyay P, Rajesh M, et al. Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death. J Pharmacol Exp Ther 2009;328:708–714
   PubMed Web of Science ®Google Scholar
• Borrelli F, Aviello G, Romano B, et al. Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis. J Mol Med (Berl) 2009;87:1111–1121
   PubMed Web of Science ®Google Scholar
• Rajesh M, Mukhopadhyay P, Batkai S, et al. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol 2010;56:2115–2125
   PubMed Web of Science ®Google Scholar
• Kozela E, Lev N, Kaushansky N, et al. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. Br J Pharmacol 2011;163:1507–1519
   PubMed Web of Science ®Google Scholar
• Li K, Feng JY, Li YY, et al. Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice. Pancreas 2013;42:123–129
   PubMed Web of Science ®Google Scholar
• Barichello T, Ceretta RA, Generoso JS, et al. Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis. Eur J Pharmacol 2012;697:158–164
   PubMed Web of Science ®Google Scholar
• Mecha M, Feliu A, Inigo PM, et al. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors. Neurobiol Dis 2013;59:141–150
   PubMed Web of Science ®Google Scholar
• Olah A, Toth BI, Borbiro I, et al. Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. J Clin Invest 2014;124:3713–3724
   PubMed Web of Science ®Google Scholar
• Izzo AA, Borrelli F, Capasso R, et al. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 2009;30:515–527
   PubMed Web of Science ®Google Scholar
• Cunha JM, Carlini EA, Pereira AE, et al. Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology 1980;21:175–185
   PubMed Web of Science ®Google Scholar
• Zuardi AW, Crippa JA, Hallak JE, et al. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res 2006;39:421–429
   PubMed Web of Science ®Google Scholar
• Zhornitsky S, Potvin S. Cannabidiol in humans-the quest for therapeutic targets. Pharmaceuticals (Basel) 2012;5:529–552
   PubMedGoogle Scholar
• Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008;22:659–661
   PubMed Web of Science ®Google Scholar
• Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med 2011;17:293–307
   PubMed Web of Science ®Google Scholar